COVID‐19 in dimethyl fumarate‐treated patients with multiple sclerosis
Author:
Publisher
Springer Science and Business Media LLC
Subject
Clinical Neurology,Neurology
Link
https://link.springer.com/content/pdf/10.1007/s00415-020-10015-1.pdf
Reference20 articles.
1. Foerch C, Friedauer L, Bauer B, Wolf T, Adam EH (2020) Severe COVID-19 infection in a patient with multiple sclerosis treated with fingolimod. Mult Scler Relat Disord 42:102180. https://doi.org/10.1016/j.msard.2020.102180
2. Suwanwongse K, Shabarek N (2020) Benign course of COVID-19 in a multiple sclerosis patient treated with Ocrelizumab. Mult Scler Relat Disord 42:102201. https://doi.org/10.1016/j.msard.2020.102201
3. Montero-Escribano P, Matías-Guiu J, Gómez-Iglesias P, Porta-Etessam J, Pytel V, Matias-Guiu JA (2020) Anti-CD20 and COVID-19 in multiple sclerosis and related disorders: a case series of 60 patients from Madrid, Spain. Mult Scler Relat Disord 42:102185. https://doi.org/10.1016/j.msard.2020.102185
4. Safavi F, Nourbakhsh B, Azimi AR (2020) B-cell depleting therapies may affect susceptibility to acute respiratory illness among patients with multiple sclerosis during the early COVID-19 epidemic in Iran. Mult Scler Relat Disord 43:102195. https://doi.org/10.1016/j.msard.2020.102195
5. Novi G, Mikulska M, Briano F et al (2020) COVID-19 in a MS patient treated with ocrelizumab: does immunosuppression have a protective role? Mult Scler Relat Disord 42:102120. https://doi.org/10.1016/j.msard.2020.102120
Cited by 42 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. In-silico analysis of SARS-CoV-2 N protein host interactors involved in Parkinson’s Disease and Dementia;2024-03-26
2. Outcomes of COVID-19 disease and its effect on disability in patients with multiple sclerosis and other allied demyelinating disorders;Clinical Neurology and Neurosurgery;2024-02
3. The possible role of nuclear factor erythroid‐2‐related factor 2 activators in the management of Covid‐19;Journal of Biochemical and Molecular Toxicology;2023-12-09
4. Towards understanding structure–property relations in materials with interpretable deep learning;npj Computational Materials;2023-12-07
5. Patients with multiple sclerosis: COVID-19 related disease activity and hospitalisations based on a nationwide cohort study;Multiple Sclerosis and Related Disorders;2023-11
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3